Constellation Pharmaceuticals Inc (CNST)

NASDAQ
33.99
0.00(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    33.97 - 34.05

CNST Overview

Prev. Close
33.99
Day's Range
33.97-34.05
Revenue
-
Open
33.98
52 wk Range
17-39.3
EPS
-3.03
Volume
0
Market Cap
1.63B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,708,909
P/E Ratio
-
Beta
-
1-Year Change
-0.66%
Shares Outstanding
48,054,654
Next Earnings Date
-
What is your sentiment on Constellation Pharmaceuticals Inc?
or
Vote to see community's results!

Constellation Pharmaceuticals Inc Company Profile

Employees
154

Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics to address serious unmet medical needs in patients with cancers associated with abnormal gene expression or drug resistance. The company’s lead product candidates include Pelabresib that is in Phase 3 clinical trials for the treatment of patients with myelofibrosis in combination with ruxolitinib. It is also developing CPI-0209 that is in Phase 1 dose escalation portion of a Phase 1/2 clinical trial to treat solid tumors; and CPI-482, which is in preclinical stage for cancer patients. The company was formerly known as Epigenetix, Inc. and changed its name to Constellation Pharmaceuticals, Inc. in March 2008. Constellation Pharmaceuticals, Inc. was incorporated in 2008 and is headquartered in Cambridge, Massachusetts. As of July 15, 2021, Constellation Pharmaceuticals, Inc. operates as a subsidiary of MorphoSys AG.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
  • classic pump and dump
    5
    • holding up well for a pump and dump
      1
  • any news?
    0
    • 15 >>> 45
      0
  • looks like you're right alix
    0
    • looks like you're right alix
      0
      • stock is going soar this month, fda approval
        0
        • stock is going soar this month, fda approval
          0
          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.